
Company Number
11304862
Next Accounts
Sep 2025
Shareholders
inuvi group limited
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
unit 10 millars brook business p, molly millars lane, wokingham, RG41 2AD
Website
puradx.comPomanda estimates the enterprise value of INUVI DIAGNOSTICS LIMITED at £5.3m based on a Turnover of £6.7m and 0.78x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INUVI DIAGNOSTICS LIMITED at £9.4m based on an EBITDA of £1.7m and a 5.62x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of INUVI DIAGNOSTICS LIMITED at £14.2m based on Net Assets of £6.2m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Inuvi Diagnostics Limited is a live company located in wokingham, RG41 2AD with a Companies House number of 11304862. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in April 2018, it's largest shareholder is inuvi group limited with a 100% stake. Inuvi Diagnostics Limited is a young, mid sized company, Pomanda has estimated its turnover at £6.7m with rapid growth in recent years.
Pomanda's financial health check has awarded Inuvi Diagnostics Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs
7 Strong
4 Regular
1 Weak
Size
annual sales of £6.7m, make it larger than the average company (£2.9m)
£6.7m - Inuvi Diagnostics Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 43%, show it is growing at a faster rate (7.2%)
43% - Inuvi Diagnostics Limited
7.2% - Industry AVG
Production
with a gross margin of 55.5%, this company has a lower cost of product (44.8%)
55.5% - Inuvi Diagnostics Limited
44.8% - Industry AVG
Profitability
an operating margin of 19.9% make it more profitable than the average company (5.7%)
19.9% - Inuvi Diagnostics Limited
5.7% - Industry AVG
Employees
with 22 employees, this is similar to the industry average (23)
22 - Inuvi Diagnostics Limited
23 - Industry AVG
Pay Structure
on an average salary of £54k, the company has an equivalent pay structure (£54k)
- Inuvi Diagnostics Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £305.9k, this is more efficient (£125.4k)
£305.9k - Inuvi Diagnostics Limited
£125.4k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is near the average (56 days)
47 days - Inuvi Diagnostics Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 46 days, this is slower than average (31 days)
46 days - Inuvi Diagnostics Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 30 days, this is in line with average (30 days)
30 days - Inuvi Diagnostics Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (25 weeks)
0 weeks - Inuvi Diagnostics Limited
25 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.3%, this is a lower level of debt than the average (53.3%)
13.3% - Inuvi Diagnostics Limited
53.3% - Industry AVG
Inuvi Diagnostics Limited's latest turnover from December 2023 is £6.7 million and the company has net assets of £6.2 million. According to their latest financial statements, Inuvi Diagnostics Limited has 22 employees and maintains cash reserves of £5.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|---|
Turnover | 6,730,684 | 4,479,610 | 9,453,064 | 2,320,028 | 383,342 | 13,560 |
Other Income Or Grants | ||||||
Cost Of Sales | 2,997,051 | 1,559,988 | 2,389,936 | 1,116,371 | 163,880 | 22,559 |
Gross Profit | 3,733,633 | 2,919,622 | 7,063,128 | 1,203,657 | 219,462 | -8,999 |
Admin Expenses | 2,395,101 | 2,018,959 | 2,055,427 | 893,519 | 401,788 | |
Operating Profit | 1,338,532 | 900,663 | 5,007,701 | 310,138 | -182,326 | |
Interest Payable | 5,796 | 5,796 | 312 | 223 | ||
Interest Receivable | 6 | |||||
Pre-Tax Profit | 1,332,736 | 894,867 | 5,007,389 | 309,921 | -182,326 | -68,933 |
Tax | -184,379 | -62,580 | -821,760 | -49,259 | -17,237 | 12,960 |
Profit After Tax | 1,148,357 | 832,287 | 4,185,629 | 260,662 | -199,563 | -55,973 |
Dividends Paid | ||||||
Retained Profit | 1,148,357 | 832,287 | 4,185,629 | 260,662 | -199,563 | -55,973 |
Employee Costs | ||||||
Number Of Employees | 22 | 20 | 22 | 13 | 7 | 4 |
EBITDA* | 1,668,512 | 1,183,312 | 5,118,504 | 338,880 | -173,364 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|---|
Tangible Assets | 495,317 | 577,621 | 404,981 | 284,017 | 24,958 | 18,154 |
Intangible Assets | ||||||
Investments & Other | 12,960 | |||||
Debtors (Due After 1 year) | ||||||
Total Fixed Assets | 495,317 | 577,621 | 404,981 | 284,017 | 24,958 | 31,114 |
Stock & work in progress | 247,000 | 186,000 | 122,000 | |||
Trade Debtors | 876,681 | 559,967 | 745,357 | 328,573 | 14,467 | 13,561 |
Group Debtors | 5,277,543 | 3,998,895 | 1,124,585 | |||
Misc Debtors | 213,237 | 153,936 | 55,366 | 81,046 | 6,184 | 13,668 |
Cash | 5,613 | 143,660 | 2,753,003 | 268,567 | 3,016 | 188 |
misc current assets | ||||||
total current assets | 6,620,074 | 5,042,458 | 4,800,311 | 678,186 | 23,667 | 27,417 |
total assets | 7,115,391 | 5,620,079 | 5,205,292 | 962,203 | 48,625 | 58,531 |
Bank overdraft | ||||||
Bank loan | ||||||
Trade Creditors | 379,576 | 122,077 | 345,652 | 284,289 | 30,714 | 20,516 |
Group/Directors Accounts | 369,536 | 250,499 | ||||
other short term finances | ||||||
hp & lease commitments | ||||||
other current liabilities | 480,611 | 371,285 | 618,108 | 249,616 | 18,571 | 93,888 |
total current liabilities | 860,187 | 493,362 | 963,760 | 903,441 | 299,784 | 114,404 |
loans | ||||||
hp & lease commitments | ||||||
Accruals and Deferred Income | ||||||
other liabilities | ||||||
provisions | 83,704 | 103,575 | 50,677 | 53,536 | 4,277 | |
total long term liabilities | 83,704 | 103,575 | 50,677 | 53,536 | 4,277 | |
total liabilities | 943,891 | 596,937 | 1,014,437 | 956,977 | 304,061 | 114,404 |
net assets | 6,171,500 | 5,023,142 | 4,190,855 | 5,226 | -255,436 | -55,873 |
total shareholders funds | 6,171,500 | 5,023,142 | 4,190,855 | 5,226 | -255,436 | -55,873 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
---|---|---|---|---|---|---|
Operating Activities | ||||||
Operating Profit | 1,338,532 | 900,663 | 5,007,701 | 310,138 | -182,326 | |
Depreciation | 329,980 | 282,649 | 110,803 | 28,742 | 8,962 | 2,581 |
Amortisation | ||||||
Tax | -184,379 | -62,580 | -821,760 | -49,259 | -17,237 | 12,960 |
Stock | 61,000 | 64,000 | 122,000 | |||
Debtors | 1,654,663 | 2,787,490 | 1,515,689 | 388,968 | -6,578 | 27,229 |
Creditors | 257,499 | -223,575 | 61,363 | 253,575 | 10,198 | 20,516 |
Accruals and Deferred Income | 109,326 | -246,823 | 368,492 | 231,045 | -75,317 | 93,888 |
Deferred Taxes & Provisions | -19,871 | 52,898 | -2,859 | 49,259 | 4,277 | |
Cash flow from operations | 115,424 | -2,148,258 | 3,086,051 | 434,532 | -244,865 | |
Investing Activities | ||||||
capital expenditure | ||||||
Change in Investments | -12,960 | 12,960 | ||||
cash flow from investments | ||||||
Financing Activities | ||||||
Bank loans | ||||||
Group/Directors Accounts | -369,536 | 119,037 | 250,499 | |||
Other Short Term Loans | ||||||
Long term loans | ||||||
Hire Purchase and Lease Commitments | ||||||
other long term liabilities | ||||||
share issue | ||||||
interest | -5,796 | -5,796 | -312 | -217 | ||
cash flow from financing | -5,795 | -5,796 | -369,848 | 118,820 | 250,499 | 100 |
cash and cash equivalents | ||||||
cash | -138,047 | -2,609,343 | 2,484,436 | 265,551 | 2,828 | 188 |
overdraft | ||||||
change in cash | -138,047 | -2,609,343 | 2,484,436 | 265,551 | 2,828 | 188 |
Perform a competitor analysis for inuvi diagnostics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in RG41 area or any other competitors across 12 key performance metrics.
INUVI DIAGNOSTICS LIMITED group structure
Inuvi Diagnostics Limited has no subsidiary companies.
Ultimate parent company
2 parents
INUVI DIAGNOSTICS LIMITED
11304862
Inuvi Diagnostics Limited currently has 5 directors. The longest serving directors include Mr Jonathan Benton (Apr 2018) and Mr Timothy Woolley (Apr 2018).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jonathan Benton | United Kingdom | 46 years | Apr 2018 | - | Director |
Mr Timothy Woolley | Wales | 52 years | Apr 2018 | - | Director |
Mr Elliott Nicholson | 43 years | Jul 2019 | - | Director | |
Mr Eduard Schmidt-Chiari | United Kingdom | 41 years | Jul 2019 | - | Director |
Mrs Dawn Oatley | United Kingdom | 61 years | Jun 2021 | - | Director |
P&L
December 2023turnover
6.7m
+50%
operating profit
1.3m
+49%
gross margin
55.5%
-14.89%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
6.2m
+0.23%
total assets
7.1m
+0.27%
cash
5.6k
-0.96%
net assets
Total assets minus all liabilities
company number
11304862
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
April 2018
age
7
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
pura diagnostics limited (June 2022)
accountant
-
auditor
MOORE KINGSTON SMITH LLP
address
unit 10 millars brook business p, molly millars lane, wokingham, RG41 2AD
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to inuvi diagnostics limited. Currently there are 3 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INUVI DIAGNOSTICS LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|